340B Drug Savings as a Lifeline: How Delaware’s FQHCs Sustain Care for Vulnerable Communities

Introduction

Delaware’s safety-net landscape is anchored by only three Federally Qualified Health Centers (FQHCs)—Westside Family Healthcare, Henrietta Johnson Medical Center, and La Red Health Center—that together serve over 45,000 residents, many uninsured or underinsured westsidehealth.org+1deha.org+1. In a context of escalating drug prices—nearly 15% nationally and 12.4% in Delaware between 2021–2022 deha.org—access to affordable medications has become critical to health equity.

The federal 340B Drug Pricing Program, established in 1992, enables safety-net providers to purchase outpatient medications at 25–50% below list price westsidehealth.orghealthcareswfl.org+12ncsl.org+12aamc.org+12. In Delaware, all three FQHCs, hospitals, and state clinics use the program in partnership with community pharmacies to deliver low-cost medications—a key strategy to maintain primary care and expand services.

Clinical leaders in Delaware emphasize that 340B “dramatically decreases the cost of prescription drugs” and funds undercompensated services such as sliding fee clinics, care coordination, and pharmacy delivery for underserved patients macpac.gov+12westsidehealth.org+12deha.org+12. Statewide, these savings represent a cornerstone of sustainable community health services, enabling Delaware’s FQHCs to fill gaps that traditional Medicaid and fee-for-service models often miss.

1: Process – Optimizing 340B through In-house Pharmacy and Data-Driven Reinvestment

In-house & Contract Pharmacy Model

Delaware’s FQHCs leverage in-house pharmacies and a statewide network of contract pharmacies to ensure patients can access 340B-priced drugs locally welch.senate.gov+1congress.gov+1. This network approach ensures continuity of care and convenience for underserved patients receiving medications for complex conditions like HIV, oncology, or diabetes.

Strategic Reinvestment

Under federal law, FQHCs must reinvest savings earned through 340B in care-enhancing services 340breport.com. Delaware FQHCs channel these savings into:

• Medication therapy management
  
  
• Sliding-fee prescriptions for uninsured patients
  
  
• Home delivery services for rural and mobility-limited individuals hrsa.gov+15congress.gov+15completerx.com+15
  
  

This chain—from deep drug discounts through local dispensing, and reinvestment into patient-centered services—exemplifies a process-centric model to maximize 340B impact.

2: People – Leadership Advocacy and Cross-Organizational Collaboration

Leadership Voices

CEOs of Delaware’s three FQHCs have publicly urged the state legislature to protect and expand 340B, citing its essential role in sustaining critical services at no taxpayer cost deha.org+6340breport.com+6completerx.com+6aamc.org+3westsidehealth.org+3welch.senate.gov+3. This advocacy has been instrumental in passing state bills safeguarding contract pharmacy access 340breport.com+4340breport.com+4welch.senate.gov+4.

Multisectoral Engagement

In Delaware, virtually all safety-net providers—FQHCs, hospitals, and clinics—participate in 340B, reflecting concerted cross-sector coordination westsidehealth.org+1rwc340b.org+1. Regular engagement with pharmacies across the state ensures equitable access, regardless of provider or locale, while optimizing supply chain logistics.

Workforce Integration

Pharmacists and pharmacy technicians are integral to FQHC care teams. With 340B funds, clinics hire pharmacy staff to:

• Conduct medication counseling
  
  
• Coordinate with providers for therapy management
  
  
• Support chronic disease protocols
  
  

This level of staffing, often unsupported by Medicaid reimbursements, is made possible by 340B viable funding.

3: Real-World Examples & Outcomes

A. Westside Family Healthcare

CEO Chris Fraser notes: “Through the 340B program, access to these discounts are at no cost to the taxpayer... It dramatically decreases the cost of prescription drugs… and props up other care that is underfunded, or otherwise not available” congress.gov340breport.com+1completerx.com+1westsidehealth.org. Westside’s pharmacy team reports that 340B savings enable expansion of delivery services and chronic care outreach to over 5,000 uninsured patients annually.

B. Hospital Safety-Net Reinforcement

In FY2023, Delaware’s adult acute care hospitals utilized $46 million in 340B benefits and reinvested more than $309 million in community services—including free screenings, mobile clinics, and transportation deha.org. This underscores 340B as a community health multiplier.

C. State Clinic Partners

State-run clinics also participate in 340B, collaborating with pharmacies to reach patients who need low-cost meds for conditions like HIV, hypertension, and oncology. This shared approach enhances medication access across the entire safety net congress.gov+15westsidehealth.org+15pmc.ncbi.nlm.nih.gov+15completerx.com.

Benefits and Results

A 2018 JAMA Health Forum study confirmed that FQHCs reinvest 340B savings into safety-net care, including pharmacy services, care coordination, and access initiatives 340breport.com. More broadly:

• 25–50% drug discounts help clinics manage rising medication costs rxbenefits.com+1healthcareswfl.org+1.
  
  
• Delaware’s $309M in community benefits reflects the scale of public service supported via 340B .
  
  
• Clinics are able to provide home delivery, sliding fees, and chronic care supports otherwise uncompensated .
  
  

These outcomes illustrate that 340B acts not just as a cost-saving tool, but a truely transformational investment in public health infrastructure.

Conclusion

Delaware’s experience shows that even a small state with just three FQHCs can harness the 340B program as a lifeline for vulnerable communities. By blending deep drug discounts, broad contract pharmacy access, strategic reinvestment in services, and active leadership advocacy, FQHCs and safety-net hospitals deliver sustained primary care, preventive services, and medication access without burdening taxpayers.

In the face of rising drug prices and mounting financial pressure, 340B ensures:

• Essential medications are affordable
  
  
• Uncompensated care is maintainable
  
  
• Workforce investment that improves adherence and outcomes
  
  

For states aiming to strengthen their safety nets, Delaware provides a practical playbook: protect 340B policy, enable multisectoral contracting, and reequip clinics with the infrastructure—pharmacy, data, people—to reinvest savings for patient impact.

Healthcare leaders, legislators, and advocates:

1. Promote laws safeguarding contract pharmacy access and 340B sustainability.
   
   
2. Support clinic pharmacy development, including staff and infrastructure.
   
   
3. Foster data-driven reinvestment to monitor and maximize patient impact.
   
   
4. Create multi-provider cooperation frameworks to ensure uniform access across communities.
   
   

Delaware shows that reinforcing 340B isn’t just fiscal—it's foundational. Join the movement to protect the program and ensure all communities can access life-saving medications and comprehensive care.

‍